Australia is carefully awaiting the arrival of retatrutide, a groundbreaking dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, https://ellavudl996351.wikinewspaper.com/4883744/novo_nordisk_s_retatrutide_australia_a_new_breakthrough_for_weight_management